Advertisement

Index by author

June 01 1998; volume 47 issue 6

A

  1. Almind, K

    1. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians.
      D Bernal, K Almind, L Yenush, M Ayoub, Y Zhang, L Rosshani, C Larsson, O Pedersen and M F White
      Diabetes 1998 Jun; 47 (6): 976-979. https://doi.org/10.2337/diabetes.47.6.976

  2. Antonellis, A

    1. Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q.
      M T Malecki, A Antonellis, P Casey, L Ji, M Wantman, J H Warram and A S Krolewski
      Diabetes 1998 Jun; 47 (6): 970-972. https://doi.org/10.2337/diabetes.47.6.970

  3. Archer, D B

    1. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.
      U Chakravarthy, R G Hayes, A W Stitt, E McAuley and D B Archer
      Diabetes 1998 Jun; 47 (6): 945-952. https://doi.org/10.2337/diabetes.47.6.945

  4. Arner, P

    1. Leptin secretion from subcutaneous and visceral adipose tissue in women.
      V Van Harmelen, S Reynisdottir, P Eriksson, A Thörne, J Hoffstedt, F Lönnqvist and P Arner
      Diabetes 1998 Jun; 47 (6): 913-917. https://doi.org/10.2337/diabetes.47.6.913

  5. Ayoub, M

    1. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians.
      D Bernal, K Almind, L Yenush, M Ayoub, Y Zhang, L Rosshani, C Larsson, O Pedersen and M F White
      Diabetes 1998 Jun; 47 (6): 976-979. https://doi.org/10.2337/diabetes.47.6.976

B

  1. Baier, L J

    1. Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women.
      L J Baier, C Wiedrich, R L Hanson and C Bogardus
      Diabetes 1998 Jun; 47 (6): 973-975. https://doi.org/10.2337/diabetes.47.6.973

  2. Behn, P S

    1. Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews.
      P S Behn, J Wasson, S Chayen, I Smolovitch, J Thomas, B Glaser and M A Permutt
      Diabetes 1998 Jun; 47 (6): 967-969. https://doi.org/10.2337/diabetes.47.6.967

  3. Bergeron, J

    1. Postprandial triglyceride response in visceral obesity in men.
      C Couillard, N Bergeron, D Prud'homme, J Bergeron, A Tremblay, C Bouchard, P Mauriège and J P Després
      Diabetes 1998 Jun; 47 (6): 953-960. https://doi.org/10.2337/diabetes.47.6.953

  4. Bergeron, N

    1. Postprandial triglyceride response in visceral obesity in men.
      C Couillard, N Bergeron, D Prud'homme, J Bergeron, A Tremblay, C Bouchard, P Mauriège and J P Després
      Diabetes 1998 Jun; 47 (6): 953-960. https://doi.org/10.2337/diabetes.47.6.953

  5. Bernal, D

    1. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians.
      D Bernal, K Almind, L Yenush, M Ayoub, Y Zhang, L Rosshani, C Larsson, O Pedersen and M F White
      Diabetes 1998 Jun; 47 (6): 976-979. https://doi.org/10.2337/diabetes.47.6.976

  6. Bogardus, C

    1. Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women.
      L J Baier, C Wiedrich, R L Hanson and C Bogardus
      Diabetes 1998 Jun; 47 (6): 973-975. https://doi.org/10.2337/diabetes.47.6.973

  7. Bouchard, C

    1. Postprandial triglyceride response in visceral obesity in men.
      C Couillard, N Bergeron, D Prud'homme, J Bergeron, A Tremblay, C Bouchard, P Mauriège and J P Després
      Diabetes 1998 Jun; 47 (6): 953-960. https://doi.org/10.2337/diabetes.47.6.953

  8. Bruni, N

    1. Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes.
      F Chatelain, J P Pégorier, C Minassian, N Bruni, S Tarpin, J Girard and G Mithieux
      Diabetes 1998 Jun; 47 (6): 882-889. https://doi.org/10.2337/diabetes.47.6.882

C

  1. Calcutt, N A

    1. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
      T F Ng, F K Lee, Z T Song, N A Calcutt, A Y Lee, S S Chung, S K Chung, D T Ng and L W Lee
      Diabetes 1998 Jun; 47 (6): 961-966. https://doi.org/10.2337/diabetes.47.6.961

  2. Casey, P

    1. Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q.
      M T Malecki, A Antonellis, P Casey, L Ji, M Wantman, J H Warram and A S Krolewski
      Diabetes 1998 Jun; 47 (6): 970-972. https://doi.org/10.2337/diabetes.47.6.970

  3. Chakravarthy, U

    1. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.
      U Chakravarthy, R G Hayes, A W Stitt, E McAuley and D B Archer
      Diabetes 1998 Jun; 47 (6): 945-952. https://doi.org/10.2337/diabetes.47.6.945

  4. Chatelain, F

    1. Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes.
      F Chatelain, J P Pégorier, C Minassian, N Bruni, S Tarpin, J Girard and G Mithieux
      Diabetes 1998 Jun; 47 (6): 882-889. https://doi.org/10.2337/diabetes.47.6.882

  5. Chayen, S

    1. Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews.
      P S Behn, J Wasson, S Chayen, I Smolovitch, J Thomas, B Glaser and M A Permutt
      Diabetes 1998 Jun; 47 (6): 967-969. https://doi.org/10.2337/diabetes.47.6.967

  6. Chen, P Y

    1. Glucose-6-phosphate and Ca2+ sequestration are mutually enhanced in microsomes from liver, brain, and heart.
      P Y Chen, P Csutora, N A Veyna-Burke and R B Marchase
      Diabetes 1998 Jun; 47 (6): 874-881. https://doi.org/10.2337/diabetes.47.6.874

  7. Cherrington, A D

    1. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
      M Shiota, P Galassetti, M Monohan, D W Neal and A D Cherrington
      Diabetes 1998 Jun; 47 (6): 867-873. https://doi.org/10.2337/diabetes.47.6.867

  8. Chung, S K

    1. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
      T F Ng, F K Lee, Z T Song, N A Calcutt, A Y Lee, S S Chung, S K Chung, D T Ng and L W Lee
      Diabetes 1998 Jun; 47 (6): 961-966. https://doi.org/10.2337/diabetes.47.6.961

  9. Chung, S S

    1. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
      T F Ng, F K Lee, Z T Song, N A Calcutt, A Y Lee, S S Chung, S K Chung, D T Ng and L W Lee
      Diabetes 1998 Jun; 47 (6): 961-966. https://doi.org/10.2337/diabetes.47.6.961

  10. Couillard, C

    1. Postprandial triglyceride response in visceral obesity in men.
      C Couillard, N Bergeron, D Prud'homme, J Bergeron, A Tremblay, C Bouchard, P Mauriège and J P Després
      Diabetes 1998 Jun; 47 (6): 953-960. https://doi.org/10.2337/diabetes.47.6.953

  11. Crijns, F R

    1. Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment.
      F R Crijns, H A Struijker Boudier and B H Wolffenbuttel
      Diabetes 1998 Jun; 47 (6): 918-923. https://doi.org/10.2337/diabetes.47.6.918

  12. Csutora, P

    1. Glucose-6-phosphate and Ca2+ sequestration are mutually enhanced in microsomes from liver, brain, and heart.
      P Y Chen, P Csutora, N A Veyna-Burke and R B Marchase
      Diabetes 1998 Jun; 47 (6): 874-881. https://doi.org/10.2337/diabetes.47.6.874

D

  1. Dallas-Yang, Q

    1. MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization.
      F M Sladek, Q Dallas-Yang and L Nepomuceno
      Diabetes 1998 Jun; 47 (6): 985-990. https://doi.org/10.2337/diabetes.47.6.985

  2. Després, J P

    1. Postprandial triglyceride response in visceral obesity in men.
      C Couillard, N Bergeron, D Prud'homme, J Bergeron, A Tremblay, C Bouchard, P Mauriège and J P Després
      Diabetes 1998 Jun; 47 (6): 953-960. https://doi.org/10.2337/diabetes.47.6.953

E

  1. Eriksson, P

    1. Leptin secretion from subcutaneous and visceral adipose tissue in women.
      V Van Harmelen, S Reynisdottir, P Eriksson, A Thörne, J Hoffstedt, F Lönnqvist and P Arner
      Diabetes 1998 Jun; 47 (6): 913-917. https://doi.org/10.2337/diabetes.47.6.913

F

  1. Flyvbjerg, A

    1. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
      I Raz, D Rubinger, M Popovtzer, H Grønbaek, O Weiss and A Flyvbjerg
      Diabetes 1998 Jun; 47 (6): 924-930. https://doi.org/10.2337/diabetes.47.6.924

G

  1. Galassetti, P

    1. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
      M Shiota, P Galassetti, M Monohan, D W Neal and A D Cherrington
      Diabetes 1998 Jun; 47 (6): 867-873. https://doi.org/10.2337/diabetes.47.6.867

  2. Giani, G

    1. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
      E F Lampeter, A Klinghammer, W A Scherbaum, E Heinze, B Haastert, G Giani and H Kolb
      Diabetes 1998 Jun; 47 (6): 980-984. https://doi.org/10.2337/diabetes.47.6.980

  3. Girard, J

    1. Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes.
      F Chatelain, J P Pégorier, C Minassian, N Bruni, S Tarpin, J Girard and G Mithieux
      Diabetes 1998 Jun; 47 (6): 882-889. https://doi.org/10.2337/diabetes.47.6.882

  4. Glaser, B

    1. Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews.
      P S Behn, J Wasson, S Chayen, I Smolovitch, J Thomas, B Glaser and M A Permutt
      Diabetes 1998 Jun; 47 (6): 967-969. https://doi.org/10.2337/diabetes.47.6.967

  5. Gopalakrishnan, V

    1. Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells.
      R L Hopfner, R V Hasnadka, T W Wilson, J R McNeill and V Gopalakrishnan
      Diabetes 1998 Jun; 47 (6): 937-944. https://doi.org/10.2337/diabetes.47.6.937

  6. Grønbaek, H

    1. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
      I Raz, D Rubinger, M Popovtzer, H Grønbaek, O Weiss and A Flyvbjerg
      Diabetes 1998 Jun; 47 (6): 924-930. https://doi.org/10.2337/diabetes.47.6.924

H

  1. Haastert, B

    1. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
      E F Lampeter, A Klinghammer, W A Scherbaum, E Heinze, B Haastert, G Giani and H Kolb
      Diabetes 1998 Jun; 47 (6): 980-984. https://doi.org/10.2337/diabetes.47.6.980

  2. Hanson, R L

    1. Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women.
      L J Baier, C Wiedrich, R L Hanson and C Bogardus
      Diabetes 1998 Jun; 47 (6): 973-975. https://doi.org/10.2337/diabetes.47.6.973

  3. Harmon, J S

    1. Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity.
      J S Harmon, Y Tanaka, L K Olson and R P Robertson
      Diabetes 1998 Jun; 47 (6): 900-904. https://doi.org/10.2337/diabetes.47.6.900

  4. Hasnadka, R V

    1. Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells.
      R L Hopfner, R V Hasnadka, T W Wilson, J R McNeill and V Gopalakrishnan
      Diabetes 1998 Jun; 47 (6): 937-944. https://doi.org/10.2337/diabetes.47.6.937

  5. Hayes, R G

    1. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.
      U Chakravarthy, R G Hayes, A W Stitt, E McAuley and D B Archer
      Diabetes 1998 Jun; 47 (6): 945-952. https://doi.org/10.2337/diabetes.47.6.945

  6. Heinze, E

    1. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
      E F Lampeter, A Klinghammer, W A Scherbaum, E Heinze, B Haastert, G Giani and H Kolb
      Diabetes 1998 Jun; 47 (6): 980-984. https://doi.org/10.2337/diabetes.47.6.980

  7. Hoffstedt, J

    1. Leptin secretion from subcutaneous and visceral adipose tissue in women.
      V Van Harmelen, S Reynisdottir, P Eriksson, A Thörne, J Hoffstedt, F Lönnqvist and P Arner
      Diabetes 1998 Jun; 47 (6): 913-917. https://doi.org/10.2337/diabetes.47.6.913

  8. Hopfner, R L

    1. Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells.
      R L Hopfner, R V Hasnadka, T W Wilson, J R McNeill and V Gopalakrishnan
      Diabetes 1998 Jun; 47 (6): 937-944. https://doi.org/10.2337/diabetes.47.6.937

I

  1. Inoguchi, T

    1. High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells.
      T Kuroki, T Inoguchi, F Umeda, F Ueda and H Nawata
      Diabetes 1998 Jun; 47 (6): 931-936. https://doi.org/10.2337/diabetes.47.6.931

J

  1. Ji, L

    1. Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q.
      M T Malecki, A Antonellis, P Casey, L Ji, M Wantman, J H Warram and A S Krolewski
      Diabetes 1998 Jun; 47 (6): 970-972. https://doi.org/10.2337/diabetes.47.6.970

K

  1. King, G L

    1. Protein kinase C activation and the development of diabetic complications.
      D Koya and G L King
      Diabetes 1998 Jun; 47 (6): 859-866. https://doi.org/10.2337/diabetes.47.6.859

  2. Klinghammer, A

    1. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
      E F Lampeter, A Klinghammer, W A Scherbaum, E Heinze, B Haastert, G Giani and H Kolb
      Diabetes 1998 Jun; 47 (6): 980-984. https://doi.org/10.2337/diabetes.47.6.980

  3. Kolb, H

    1. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
      E F Lampeter, A Klinghammer, W A Scherbaum, E Heinze, B Haastert, G Giani and H Kolb
      Diabetes 1998 Jun; 47 (6): 980-984. https://doi.org/10.2337/diabetes.47.6.980

  4. Koya, D

    1. Protein kinase C activation and the development of diabetic complications.
      D Koya and G L King
      Diabetes 1998 Jun; 47 (6): 859-866. https://doi.org/10.2337/diabetes.47.6.859

  5. Krolewski, A S

    1. Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q.
      M T Malecki, A Antonellis, P Casey, L Ji, M Wantman, J H Warram and A S Krolewski
      Diabetes 1998 Jun; 47 (6): 970-972. https://doi.org/10.2337/diabetes.47.6.970

  6. Kuroki, T

    1. High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells.
      T Kuroki, T Inoguchi, F Umeda, F Ueda and H Nawata
      Diabetes 1998 Jun; 47 (6): 931-936. https://doi.org/10.2337/diabetes.47.6.931

L

  1. Lampeter, E F

    1. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
      E F Lampeter, A Klinghammer, W A Scherbaum, E Heinze, B Haastert, G Giani and H Kolb
      Diabetes 1998 Jun; 47 (6): 980-984. https://doi.org/10.2337/diabetes.47.6.980

  2. Larsson, C

    1. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians.
      D Bernal, K Almind, L Yenush, M Ayoub, Y Zhang, L Rosshani, C Larsson, O Pedersen and M F White
      Diabetes 1998 Jun; 47 (6): 976-979. https://doi.org/10.2337/diabetes.47.6.976

  3. Lee, A Y

    1. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
      T F Ng, F K Lee, Z T Song, N A Calcutt, A Y Lee, S S Chung, S K Chung, D T Ng and L W Lee
      Diabetes 1998 Jun; 47 (6): 961-966. https://doi.org/10.2337/diabetes.47.6.961

  4. Lee, F K

    1. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
      T F Ng, F K Lee, Z T Song, N A Calcutt, A Y Lee, S S Chung, S K Chung, D T Ng and L W Lee
      Diabetes 1998 Jun; 47 (6): 961-966. https://doi.org/10.2337/diabetes.47.6.961

  5. Lee, L W

    1. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
      T F Ng, F K Lee, Z T Song, N A Calcutt, A Y Lee, S S Chung, S K Chung, D T Ng and L W Lee
      Diabetes 1998 Jun; 47 (6): 961-966. https://doi.org/10.2337/diabetes.47.6.961

  6. Liblau, P

    1. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice.
      R Tisch, R S Liblau, X D Yang, P Liblau and H O McDevitt
      Diabetes 1998 Jun; 47 (6): 894-899. https://doi.org/10.2337/diabetes.47.6.894

  7. Liblau, R S

    1. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice.
      R Tisch, R S Liblau, X D Yang, P Liblau and H O McDevitt
      Diabetes 1998 Jun; 47 (6): 894-899. https://doi.org/10.2337/diabetes.47.6.894

  8. Lönnqvist, F

    1. Leptin secretion from subcutaneous and visceral adipose tissue in women.
      V Van Harmelen, S Reynisdottir, P Eriksson, A Thörne, J Hoffstedt, F Lönnqvist and P Arner
      Diabetes 1998 Jun; 47 (6): 913-917. https://doi.org/10.2337/diabetes.47.6.913

M

  1. Malecki, M T

    1. Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q.
      M T Malecki, A Antonellis, P Casey, L Ji, M Wantman, J H Warram and A S Krolewski
      Diabetes 1998 Jun; 47 (6): 970-972. https://doi.org/10.2337/diabetes.47.6.970

  2. Marchase, R B

    1. Glucose-6-phosphate and Ca2+ sequestration are mutually enhanced in microsomes from liver, brain, and heart.
      P Y Chen, P Csutora, N A Veyna-Burke and R B Marchase
      Diabetes 1998 Jun; 47 (6): 874-881. https://doi.org/10.2337/diabetes.47.6.874

  3. Mauriège, P

    1. Postprandial triglyceride response in visceral obesity in men.
      C Couillard, N Bergeron, D Prud'homme, J Bergeron, A Tremblay, C Bouchard, P Mauriège and J P Després
      Diabetes 1998 Jun; 47 (6): 953-960. https://doi.org/10.2337/diabetes.47.6.953

  4. McAuley, E

    1. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.
      U Chakravarthy, R G Hayes, A W Stitt, E McAuley and D B Archer
      Diabetes 1998 Jun; 47 (6): 945-952. https://doi.org/10.2337/diabetes.47.6.945

  5. McDevitt, H O

    1. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice.
      R Tisch, R S Liblau, X D Yang, P Liblau and H O McDevitt
      Diabetes 1998 Jun; 47 (6): 894-899. https://doi.org/10.2337/diabetes.47.6.894

  6. McNeill, J R

    1. Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells.
      R L Hopfner, R V Hasnadka, T W Wilson, J R McNeill and V Gopalakrishnan
      Diabetes 1998 Jun; 47 (6): 937-944. https://doi.org/10.2337/diabetes.47.6.937

  7. Minassian, C

    1. Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes.
      F Chatelain, J P Pégorier, C Minassian, N Bruni, S Tarpin, J Girard and G Mithieux
      Diabetes 1998 Jun; 47 (6): 882-889. https://doi.org/10.2337/diabetes.47.6.882

  8. Mithieux, G

    1. Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes.
      F Chatelain, J P Pégorier, C Minassian, N Bruni, S Tarpin, J Girard and G Mithieux
      Diabetes 1998 Jun; 47 (6): 882-889. https://doi.org/10.2337/diabetes.47.6.882

  9. Monohan, M

    1. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
      M Shiota, P Galassetti, M Monohan, D W Neal and A D Cherrington
      Diabetes 1998 Jun; 47 (6): 867-873. https://doi.org/10.2337/diabetes.47.6.867

  10. Mori, M

    1. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin.
      Y Uehara, H Shimizu, K Ohtani, N Sato and M Mori
      Diabetes 1998 Jun; 47 (6): 890-893. https://doi.org/10.2337/diabetes.47.6.890

N

  1. Nawata, H

    1. High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells.
      T Kuroki, T Inoguchi, F Umeda, F Ueda and H Nawata
      Diabetes 1998 Jun; 47 (6): 931-936. https://doi.org/10.2337/diabetes.47.6.931

  2. Neal, D W

    1. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
      M Shiota, P Galassetti, M Monohan, D W Neal and A D Cherrington
      Diabetes 1998 Jun; 47 (6): 867-873. https://doi.org/10.2337/diabetes.47.6.867

  3. Nepomuceno, L

    1. MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization.
      F M Sladek, Q Dallas-Yang and L Nepomuceno
      Diabetes 1998 Jun; 47 (6): 985-990. https://doi.org/10.2337/diabetes.47.6.985

  4. Ng, D T

    1. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
      T F Ng, F K Lee, Z T Song, N A Calcutt, A Y Lee, S S Chung, S K Chung, D T Ng and L W Lee
      Diabetes 1998 Jun; 47 (6): 961-966. https://doi.org/10.2337/diabetes.47.6.961

  5. Ng, T F

    1. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
      T F Ng, F K Lee, Z T Song, N A Calcutt, A Y Lee, S S Chung, S K Chung, D T Ng and L W Lee
      Diabetes 1998 Jun; 47 (6): 961-966. https://doi.org/10.2337/diabetes.47.6.961

O

  1. Ohtani, K

    1. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin.
      Y Uehara, H Shimizu, K Ohtani, N Sato and M Mori
      Diabetes 1998 Jun; 47 (6): 890-893. https://doi.org/10.2337/diabetes.47.6.890

  2. Olson, L K

    1. Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity.
      J S Harmon, Y Tanaka, L K Olson and R P Robertson
      Diabetes 1998 Jun; 47 (6): 900-904. https://doi.org/10.2337/diabetes.47.6.900

P

  1. Pedersen, O

    1. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians.
      D Bernal, K Almind, L Yenush, M Ayoub, Y Zhang, L Rosshani, C Larsson, O Pedersen and M F White
      Diabetes 1998 Jun; 47 (6): 976-979. https://doi.org/10.2337/diabetes.47.6.976

  2. Pégorier, J P

    1. Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes.
      F Chatelain, J P Pégorier, C Minassian, N Bruni, S Tarpin, J Girard and G Mithieux
      Diabetes 1998 Jun; 47 (6): 882-889. https://doi.org/10.2337/diabetes.47.6.882

  3. Permutt, M A

    1. Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews.
      P S Behn, J Wasson, S Chayen, I Smolovitch, J Thomas, B Glaser and M A Permutt
      Diabetes 1998 Jun; 47 (6): 967-969. https://doi.org/10.2337/diabetes.47.6.967

  4. Popovtzer, M

    1. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
      I Raz, D Rubinger, M Popovtzer, H Grønbaek, O Weiss and A Flyvbjerg
      Diabetes 1998 Jun; 47 (6): 924-930. https://doi.org/10.2337/diabetes.47.6.924

  5. Prud'homme, D

    1. Postprandial triglyceride response in visceral obesity in men.
      C Couillard, N Bergeron, D Prud'homme, J Bergeron, A Tremblay, C Bouchard, P Mauriège and J P Després
      Diabetes 1998 Jun; 47 (6): 953-960. https://doi.org/10.2337/diabetes.47.6.953

R

  1. Raz, I

    1. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
      I Raz, D Rubinger, M Popovtzer, H Grønbaek, O Weiss and A Flyvbjerg
      Diabetes 1998 Jun; 47 (6): 924-930. https://doi.org/10.2337/diabetes.47.6.924

  2. Reynisdottir, S

    1. Leptin secretion from subcutaneous and visceral adipose tissue in women.
      V Van Harmelen, S Reynisdottir, P Eriksson, A Thörne, J Hoffstedt, F Lönnqvist and P Arner
      Diabetes 1998 Jun; 47 (6): 913-917. https://doi.org/10.2337/diabetes.47.6.913

  3. Robertson, R P

    1. Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity.
      J S Harmon, Y Tanaka, L K Olson and R P Robertson
      Diabetes 1998 Jun; 47 (6): 900-904. https://doi.org/10.2337/diabetes.47.6.900

  4. Rosshani, L

    1. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians.
      D Bernal, K Almind, L Yenush, M Ayoub, Y Zhang, L Rosshani, C Larsson, O Pedersen and M F White
      Diabetes 1998 Jun; 47 (6): 976-979. https://doi.org/10.2337/diabetes.47.6.976

  5. Rubinger, D

    1. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
      I Raz, D Rubinger, M Popovtzer, H Grønbaek, O Weiss and A Flyvbjerg
      Diabetes 1998 Jun; 47 (6): 924-930. https://doi.org/10.2337/diabetes.47.6.924

S

  1. Sato, N

    1. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin.
      Y Uehara, H Shimizu, K Ohtani, N Sato and M Mori
      Diabetes 1998 Jun; 47 (6): 890-893. https://doi.org/10.2337/diabetes.47.6.890

  2. Scherbaum, W A

    1. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
      E F Lampeter, A Klinghammer, W A Scherbaum, E Heinze, B Haastert, G Giani and H Kolb
      Diabetes 1998 Jun; 47 (6): 980-984. https://doi.org/10.2337/diabetes.47.6.980

  3. Sharp, G W

    1. Atypical protein kinase C isozyme zeta mediates carbachol-stimulated insulin secretion in RINm5F cells.
      S H Tang and G W Sharp
      Diabetes 1998 Jun; 47 (6): 905-912. https://doi.org/10.2337/diabetes.47.6.905

  4. Shimizu, H

    1. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin.
      Y Uehara, H Shimizu, K Ohtani, N Sato and M Mori
      Diabetes 1998 Jun; 47 (6): 890-893. https://doi.org/10.2337/diabetes.47.6.890

  5. Shiota, M

    1. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
      M Shiota, P Galassetti, M Monohan, D W Neal and A D Cherrington
      Diabetes 1998 Jun; 47 (6): 867-873. https://doi.org/10.2337/diabetes.47.6.867

  6. Sladek, F M

    1. MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization.
      F M Sladek, Q Dallas-Yang and L Nepomuceno
      Diabetes 1998 Jun; 47 (6): 985-990. https://doi.org/10.2337/diabetes.47.6.985

  7. Smolovitch, I

    1. Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews.
      P S Behn, J Wasson, S Chayen, I Smolovitch, J Thomas, B Glaser and M A Permutt
      Diabetes 1998 Jun; 47 (6): 967-969. https://doi.org/10.2337/diabetes.47.6.967

  8. Song, Z T

    1. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
      T F Ng, F K Lee, Z T Song, N A Calcutt, A Y Lee, S S Chung, S K Chung, D T Ng and L W Lee
      Diabetes 1998 Jun; 47 (6): 961-966. https://doi.org/10.2337/diabetes.47.6.961

  9. Stitt, A W

    1. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.
      U Chakravarthy, R G Hayes, A W Stitt, E McAuley and D B Archer
      Diabetes 1998 Jun; 47 (6): 945-952. https://doi.org/10.2337/diabetes.47.6.945

  10. Struijker Boudier, H A

    1. Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment.
      F R Crijns, H A Struijker Boudier and B H Wolffenbuttel
      Diabetes 1998 Jun; 47 (6): 918-923. https://doi.org/10.2337/diabetes.47.6.918

T

  1. Tanaka, Y

    1. Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity.
      J S Harmon, Y Tanaka, L K Olson and R P Robertson
      Diabetes 1998 Jun; 47 (6): 900-904. https://doi.org/10.2337/diabetes.47.6.900

  2. Tang, S H

    1. Atypical protein kinase C isozyme zeta mediates carbachol-stimulated insulin secretion in RINm5F cells.
      S H Tang and G W Sharp
      Diabetes 1998 Jun; 47 (6): 905-912. https://doi.org/10.2337/diabetes.47.6.905

  3. Tarpin, S

    1. Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes.
      F Chatelain, J P Pégorier, C Minassian, N Bruni, S Tarpin, J Girard and G Mithieux
      Diabetes 1998 Jun; 47 (6): 882-889. https://doi.org/10.2337/diabetes.47.6.882

  4. Thomas, J

    1. Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews.
      P S Behn, J Wasson, S Chayen, I Smolovitch, J Thomas, B Glaser and M A Permutt
      Diabetes 1998 Jun; 47 (6): 967-969. https://doi.org/10.2337/diabetes.47.6.967

  5. Thörne, A

    1. Leptin secretion from subcutaneous and visceral adipose tissue in women.
      V Van Harmelen, S Reynisdottir, P Eriksson, A Thörne, J Hoffstedt, F Lönnqvist and P Arner
      Diabetes 1998 Jun; 47 (6): 913-917. https://doi.org/10.2337/diabetes.47.6.913

  6. Tisch, R

    1. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice.
      R Tisch, R S Liblau, X D Yang, P Liblau and H O McDevitt
      Diabetes 1998 Jun; 47 (6): 894-899. https://doi.org/10.2337/diabetes.47.6.894

  7. Tremblay, A

    1. Postprandial triglyceride response in visceral obesity in men.
      C Couillard, N Bergeron, D Prud'homme, J Bergeron, A Tremblay, C Bouchard, P Mauriège and J P Després
      Diabetes 1998 Jun; 47 (6): 953-960. https://doi.org/10.2337/diabetes.47.6.953

U

  1. Ueda, F

    1. High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells.
      T Kuroki, T Inoguchi, F Umeda, F Ueda and H Nawata
      Diabetes 1998 Jun; 47 (6): 931-936. https://doi.org/10.2337/diabetes.47.6.931

  2. Uehara, Y

    1. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin.
      Y Uehara, H Shimizu, K Ohtani, N Sato and M Mori
      Diabetes 1998 Jun; 47 (6): 890-893. https://doi.org/10.2337/diabetes.47.6.890

  3. Umeda, F

    1. High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells.
      T Kuroki, T Inoguchi, F Umeda, F Ueda and H Nawata
      Diabetes 1998 Jun; 47 (6): 931-936. https://doi.org/10.2337/diabetes.47.6.931

V

  1. Van Harmelen, V

    1. Leptin secretion from subcutaneous and visceral adipose tissue in women.
      V Van Harmelen, S Reynisdottir, P Eriksson, A Thörne, J Hoffstedt, F Lönnqvist and P Arner
      Diabetes 1998 Jun; 47 (6): 913-917. https://doi.org/10.2337/diabetes.47.6.913

  2. Veyna-Burke, N A

    1. Glucose-6-phosphate and Ca2+ sequestration are mutually enhanced in microsomes from liver, brain, and heart.
      P Y Chen, P Csutora, N A Veyna-Burke and R B Marchase
      Diabetes 1998 Jun; 47 (6): 874-881. https://doi.org/10.2337/diabetes.47.6.874

W

  1. Wantman, M

    1. Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q.
      M T Malecki, A Antonellis, P Casey, L Ji, M Wantman, J H Warram and A S Krolewski
      Diabetes 1998 Jun; 47 (6): 970-972. https://doi.org/10.2337/diabetes.47.6.970

  2. Warram, J H

    1. Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q.
      M T Malecki, A Antonellis, P Casey, L Ji, M Wantman, J H Warram and A S Krolewski
      Diabetes 1998 Jun; 47 (6): 970-972. https://doi.org/10.2337/diabetes.47.6.970

  3. Wasson, J

    1. Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews.
      P S Behn, J Wasson, S Chayen, I Smolovitch, J Thomas, B Glaser and M A Permutt
      Diabetes 1998 Jun; 47 (6): 967-969. https://doi.org/10.2337/diabetes.47.6.967

  4. Weiss, O

    1. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
      I Raz, D Rubinger, M Popovtzer, H Grønbaek, O Weiss and A Flyvbjerg
      Diabetes 1998 Jun; 47 (6): 924-930. https://doi.org/10.2337/diabetes.47.6.924

  5. White, M F

    1. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians.
      D Bernal, K Almind, L Yenush, M Ayoub, Y Zhang, L Rosshani, C Larsson, O Pedersen and M F White
      Diabetes 1998 Jun; 47 (6): 976-979. https://doi.org/10.2337/diabetes.47.6.976

  6. Wiedrich, C

    1. Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women.
      L J Baier, C Wiedrich, R L Hanson and C Bogardus
      Diabetes 1998 Jun; 47 (6): 973-975. https://doi.org/10.2337/diabetes.47.6.973

  7. Wilson, T W

    1. Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells.
      R L Hopfner, R V Hasnadka, T W Wilson, J R McNeill and V Gopalakrishnan
      Diabetes 1998 Jun; 47 (6): 937-944. https://doi.org/10.2337/diabetes.47.6.937

  8. Wolffenbuttel, B H

    1. Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment.
      F R Crijns, H A Struijker Boudier and B H Wolffenbuttel
      Diabetes 1998 Jun; 47 (6): 918-923. https://doi.org/10.2337/diabetes.47.6.918

Y

  1. Yang, X D

    1. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice.
      R Tisch, R S Liblau, X D Yang, P Liblau and H O McDevitt
      Diabetes 1998 Jun; 47 (6): 894-899. https://doi.org/10.2337/diabetes.47.6.894

  2. Yenush, L

    1. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians.
      D Bernal, K Almind, L Yenush, M Ayoub, Y Zhang, L Rosshani, C Larsson, O Pedersen and M F White
      Diabetes 1998 Jun; 47 (6): 976-979. https://doi.org/10.2337/diabetes.47.6.976

Z

  1. Zhang, Y

    1. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians.
      D Bernal, K Almind, L Yenush, M Ayoub, Y Zhang, L Rosshani, C Larsson, O Pedersen and M F White
      Diabetes 1998 Jun; 47 (6): 976-979. https://doi.org/10.2337/diabetes.47.6.976
Back to top